HC Wainwright Forecasts Strong Price Appreciation for Larimar Therapeutics (NASDAQ:LRMR) Stock
Larimar Therapeutics (NASDAQ:LRMR – Get Free Report) had its target price increased by HC Wainwright from $15.00 to $16.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright also issued estimates for Larimar Therapeutics’ Q1 2025 earnings at ($0.43) EPS, Q2 2025 earnings […]
Larimar Therapeutics (NASDAQ:LRMR – Get Free Report) had its target price increased by HC Wainwright from $15.00 to $16.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright also issued estimates for Larimar Therapeutics’ Q1 2025 earnings at ($0.43) EPS, Q2 2025 earnings […]
